1. Home
  2. WGSWW vs BHFAN Comparison

WGSWW vs BHFAN Comparison

Compare WGSWW & BHFAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • BHFAN
  • Stock Information
  • Founded
  • WGSWW 2017
  • BHFAN N/A
  • Country
  • WGSWW United States
  • BHFAN United States
  • Employees
  • WGSWW 1000
  • BHFAN 1400
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • BHFAN Life Insurance
  • Sector
  • WGSWW Technology
  • BHFAN Finance
  • Exchange
  • WGSWW Nasdaq
  • BHFAN Nasdaq
  • Market Cap
  • WGSWW N/A
  • BHFAN N/A
  • IPO Year
  • WGSWW N/A
  • BHFAN N/A
  • Fundamental
  • Price
  • WGSWW $0.06
  • BHFAN $15.69
  • Analyst Decision
  • WGSWW
  • BHFAN
  • Analyst Count
  • WGSWW 0
  • BHFAN 0
  • Target Price
  • WGSWW N/A
  • BHFAN N/A
  • AVG Volume (30 Days)
  • WGSWW 36.6K
  • BHFAN N/A
  • Earning Date
  • WGSWW 02-18-2025
  • BHFAN N/A
  • Dividend Yield
  • WGSWW N/A
  • BHFAN N/A
  • EPS Growth
  • WGSWW N/A
  • BHFAN N/A
  • EPS
  • WGSWW N/A
  • BHFAN N/A
  • Revenue
  • WGSWW $305,450,000.00
  • BHFAN N/A
  • Revenue This Year
  • WGSWW N/A
  • BHFAN N/A
  • Revenue Next Year
  • WGSWW N/A
  • BHFAN N/A
  • P/E Ratio
  • WGSWW N/A
  • BHFAN N/A
  • Revenue Growth
  • WGSWW 50.79
  • BHFAN N/A
  • 52 Week Low
  • WGSWW $0.17
  • BHFAN N/A
  • 52 Week High
  • WGSWW $0.21
  • BHFAN N/A
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW N/A
  • BHFAN 47.26
  • Support Level
  • WGSWW N/A
  • BHFAN $15.55
  • Resistance Level
  • WGSWW N/A
  • BHFAN $16.00
  • Average True Range (ATR)
  • WGSWW 0.00
  • BHFAN 0.40
  • MACD
  • WGSWW 0.00
  • BHFAN 0.05
  • Stochastic Oscillator
  • WGSWW 0.00
  • BHFAN 36.17

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.

Share on Social Networks: